Patrick Reichl
- Hepatology top 10%
-
- Pancreatic and Hepatic Oncology Research 4
-
- Phagocytosis and Immune Regulation 3
-
- MicroRNA in disease regulation 1
-
- Protein Kinase Regulation and GTPase Signaling 1
- Wnt/β-catenin signaling in development and cancer 1
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 1
-
- Cancer Research and Treatments 1
-
- Hippo pathway signaling and YAP/TAZ 1
- Co-authors
- Wolfgang MikulitsMarkus GrubingerSeyedhossein AharinejadKarin ZinsTrevor LucasDietmar AbrahamChristian ReichelWolfgang Sieghart
- Cited by
- HepatologyOncologyImmunology
In The Last Decade
Patrick Reichl
6 papers receiving 397 citations
Peers
Comparison fields: 5 of 56
- Hepatology 65
- Oncology 151
- Immunology 114
- Cancer Research 76
- Molecular Biology 232
Countries citing papers authored by Patrick Reichl
This map shows the geographic impact of Patrick Reichl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Reichl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Reichl more than expected).
Fields of papers citing papers by Patrick Reichl
This network shows the impact of papers produced by Patrick Reichl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Reichl. The network helps show where Patrick Reichl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Patrick Reichl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 65 | |
| 2 | 2015 | 3 | |
| 3 | 2014 | 129 | |
| 4 | 2014 | 43 | |
| 5 | 2013 | 82 | |
| 6 | 2012 | 83 |
About Patrick Reichl
Patrick Reichl is a scholar working on Oncology, Immunology and Hepatology, having authored 6 papers that have together received 405 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (4 papers), Phagocytosis and Immune Regulation (3 papers), Protein Kinase Regulation and GTPase Signaling (1 paper), Wnt/β-catenin signaling in development and cancer (1 paper), Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper), Cancer Research and Treatments (1 paper), MicroRNA in disease regulation (1 paper) and Hippo pathway signaling and YAP/TAZ (1 paper). The work is most often cited by research in Hepatology (65 citations), Oncology (151 citations) and Immunology (114 citations). Patrick Reichl has collaborated with scholars based in Austria, Hong Kong and Germany. Frequent co-authors include Wolfgang Mikulits, Markus Grubinger, Seyedhossein Aharinejad, Karin Zins, Trevor Lucas, Dietmar Abraham, Christian Reichel, Wolfgang Sieghart, Heidemarie Huber and Markus Peck‐Radosavljevic. Their work appears in journals such as Current Pharmaceutical Design, International Journal of Cancer, Oncology Reports, Journal of Hepatology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.